Breaking News Instant updates and real-time market news.

CHTR

Charter

, CL

Colgate-Palmolive

20:25
10/25/18
10/25
20:25
10/25/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Charter Communications (CHTR), consensus $1.04... Colgate-Palmolive (CL), consensus 72c... Phillips 66 (PSX), consensus $2.45... Moody's (MCO), consensus $1.78... Zimmer Biomet (ZBH), consensus $1.61... Weyerhaeuser (WY), consensus 37c... Goodyear Tire (GT), consensus 76c.

CHTR

Charter

CL

Colgate-Palmolive

PSX

Phillips 66

MCO

Moody's

ZBH

Zimmer Biomet

WY

Weyerhaeuser

GT

Goodyear Tire

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

CHTR Charter

07/30/18
07/30/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA UPGRADES AT&T TO BUY: Bank of America Merrill Lynch upgraded AT&T (T) to Buy from Neutral as analyst David Barden is positive on AT&T's 20-year low P/E multiple, Timer Warner merger benefits, favorable emerging wireless business trends, and a call option on value extraction from the merger of AT&T's distribution network with Time Warner's content and ad inventory. He keeps a $37 price target on AT&T shares. DEUTSCHE UPS JUNIPER IN 'CONTRARIAN' CALL: Deutsche Bank analyst Vijay Bhagavath upgraded Juniper Networks (JNPR) to Buy from Hold and raised his price target for the shares to $32 from $25. The analyst said he's "going against the grain" and making a "contrarian call." The post-earnings selloff on the "better than feared" Q2 results and below consensus Q3 guidance, which is primarily related to switch router upgrade timing at a handful of cloud and service provider customers, provides a "reasonable entry point." He believes "robust" switch router and next generation security refresh cycles will start in fiscal 2019 and that Juniper's fundamentals will improve from FY19 through FY21. STIFEL CUTS SYNCHRONOS TO SELL: Stifel analyst Tom Roderick downgraded Synchronoss (SNCR) to Sell from Hold, stating that recent filings reveal that liquidity issues loom, the company is "out of levers, and time is not on their side." The turnaround required to keep the company from fundraising "feels Herculean," added Roderick, who lowered his price target on Synchronoss shares to $3 from $8. BUCKINGHAM SAYS FORCED SALE OF CHARTER ASSETS 'UNLIKELY': Buckingham analyst Matthew Harrigan noted that New York's Public Service Commission has moved to push Charter (CHTR) out of the state and presented the company with a 60 day ultimatum to find a buyer for its assets there due to what it views as "repeated failures" to honor its commitments around the 2016 merger with Time Warner Cable. While he thinks an extended court battle seems "virtually certain," Harrigan does not see much likelihood of any forced disposition of its New York State assets. He keeps a Buy rating and $397 price target on Charter shares.
08/02/18
RILY
08/02/18
NO CHANGE
Target $62
RILY
Buy
GCI Liberty price target lowered to $62 from $70 at B. Riley FBR
B. Riley FBR analyst Barton Crockett lowered his price target for GCI Liberty (GLIBA) to $62 after updating his sum-of-the-parts analysis. The analyst still sees potential upside of 30%-plus, likely realized over next couple years via a merger with Charter Communications (CHTR). Charter is likely interested in GCI Liberty because of its holdings of Charter-related equity and its Alaskan cable business, Crockett tells investors in a research note. He keeps a Buy rating on GCI.
10/23/18
GUGG
10/23/18
INITIATION
Target $400
GUGG
Buy
Charter assumed with a Buy at Guggenheim
Guggenheim analyst Mike McCormack assumed coverage of Charter Communications with a Buy rating and $400 price target.
10/23/18
10/23/18
NO CHANGE

Guggenheim assumes select Cable/Satellite names with positive outlook
Guggenheim analyst Mike McCormack assumed coverage of select Cable & Satellite Services companies with a positive outlook, saying that while each company is facing "video headwinds", they also offer shared catalysts of "the demand for broadband connectivity, increasingly faster speeds, and new wireless products". The analyst assumes Altice USA (ATUS), Charter (CHTR) and Dish (DISH) with Buy ratings and Comcast (CMCSA) with a Neutral rating, adding that its "business is in transition" with core risks around domestic and international operations. McCormack puts a $23 price target on Altice USA, $400 price target on Charter, $38 price target on Comcast, and a $50 price target on Dish, adding that the "importance of the bundle is diminishing" and the focus shifts to the scope of connectivity coverage. The analyst also expects the "younger demographic" to continue to seek out "lower cost, apps-based alternatives, with an eye towards free/cheap, but high-demand content".
CL Colgate-Palmolive

07/30/18
07/30/18
DOWNGRADE
Target $65

Neutral
Colgate-Palmolive downgraded to Neutral on margin, volume pressure at Macquarie
As previously reported, Macquarie downgraded Colgate-Palmolive to Neutral from Outperform and cut its price target to $65 from $74. Analyst Caroline Levy does not expect growth to accelerate over the next several quarters and lowered her FY18 organic sales estimate to .5% from 1% and FY19 to 2.2% from 3.2%. Levy comments organic sales growth will be underwhelming in Q2 and to remain that way the rest of the year as Colgate attempts to protect margins with price hikes beginning in Q3, putting even more pressure on volumes. Further, Levy expects 2H margins to be hurt by higher freight costs, rising commodity costs, and FX headwinds.
07/30/18
07/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Colgate-Palmolive (CL) downgraded to Neutral from Outperform at Macquarie with analyst Caroline Levy saying she does not expect growth to accelerate over the next several quarters and lowered her FY18 organic sales estimate to 0.5% from 1% and FY19 to 2.2% from 3.2%. 2. Alaska Air (ALK) downgraded to Neutral from Outperform at Macquarie. 3. Perrigo (PRGO) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg citing the challenges faced by the company around the "industry-wide price erosion, a legal investigation, and a reduction in FDA approvals." 4. Synchronoss (SNCR) downgraded to Sell from Hold at Stifel with analyst Tom Roderick saying recent filings reveal that liquidity issues loom, the company is "out of levers, and time is not on their side." 5. Synchrony (SYF) downgraded to Equal Weight from Overweight at Barclays with analyst Mark Devries saying the loss of the Walmart (WMT) credit card business heightens contract renewal risk and caps upside in the stock. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/18/18
ARGS
09/18/18
NO CHANGE
Target $75
ARGS
Buy
Colgate-Palmolive price target raised to $75 from $72 at Argus
Argus analyst Chris Graja raised his price target on Colgate Palmolive to $75 and kept his Buy rating, saying the company's valuation multiple of 23-times trailing earnings vs. 26.8-times historical average is attractive. The analyst is also raising his 5-year earnings growth forecast for Colgate Palmolive to 7% from 6%, citing its expansion opportunities in the emerging markets. Graja contends that the markets' "rapid population increases, an expanding middle class, and the underutilization of personal care products" position the company to be successful based on its brand recognition and leading market share.
09/20/18
ATLE
09/20/18
INITIATION
Target $71
ATLE
Neutral
Colgate-Palmolive initiated with a Neutral at Atlantic Equities
Atlantic Equities analyst Edward Lewis initiated Colgate-Palmolive with a Neutral and $71 price target due to ongoing challenges in Latin America and Asia that will limit growth.
PSX Phillips 66

08/01/18
MZHO
08/01/18
INITIATION
Target $124
MZHO
Neutral
Phillips 66 initiated with a Neutral at Mizuho
Mizuho initiated Phillips 66 with a Neutral and $124 rice target.
10/03/18
LEHM
10/03/18
UPGRADE
Target $128
LEHM
Equal Weight
Phillips 66 upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Paul Cheng upgraded Phillips 66 to Equal Weight while lowering his price target for the shares to $128 from $133. The analyst believes the valuation is fairer following the stock's relative underperformance in 2018.
10/03/18
LEHM
10/03/18
NO CHANGE
LEHM
Barclays upgrades Phillips 66, downgrades CVR Refining to Underweight
Barclays analyst Paul Cheng upgrades Phillips 66 (PSX) to Equal Weight from Underweight while lowering his price target for the shares to $128 from $133. The analyst cites valuation for the upgrade, noting the stock is up 13% year-to-date while peers are up 30%. Cheng coupled the upgrade with a downgrade of CVR Refining (CVRR) to Underweight from Equal Weight. The analyst also cut his price target for the shares to $20 from $24. Earlier this year, CVR Energy (CVI) purchased a number of CVR Refining units and the parent plus affiliates now own around 85% of the partnership, Cheng tells investors in a research note. According to the partnership agreement, once the general partner and affiliates own more than 80% of CVR Refining common units, CVR Energy can call the remaining units at the higher of the market price or the last 20 days' moving average, the analyst adds. As such, he sees little reason to own CVR Refining specifically, saying the call provision "essentially eliminates any upside to the units."
10/16/18
JEFF
10/16/18
UPGRADE
Target $108
JEFF
Hold
Phillips 66 upgraded to Hold from Underperform at Jefferies
Jefferies analyst Christopher Sighinolfi upgraded Phillips 66 to Hold and raised his price target for the shares to $108 from $90.
MCO Moody's

10/09/18
UBSW
10/09/18
NO CHANGE
UBSW
Buy
Ratings agencies Q3 estimates still too high, says UBS
UBS analyst Alex Kramm adjusted his estimates for the rating agencies ahead of Q3 results but still remains below Street expectations for both Moody's (MCO) and S&P Global (SPGI). He likes the setup for better refi activity in 2019, but he expects continued choppiness in the near-term on the back of rising rates and volatility.
08/31/18
STFL
08/31/18
NO CHANGE
STFL
Hold
Moody's, S&P may underperform if debt issuance trends continue, says Stifel
Stifel analyst Shlomo Rosenbaum said that it appears August has been a particularly weak month for debt issuance, which means an "exceedingly strong September" will be needed to achieve consensus estimates for the respective ratings businesses of Moody's (MCO) and S&P Global (SPGI). Structured finance deals, which are particularly lucrative, have been offsetting year-over-year issuance declines in other parts of the ratings business, but the dollar and issuance volumes in the structured securities and loans areas are both down materially quarter-to-date, added Rosenbaum. He maintains Hold ratings on both Moody's and S&P Global.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
08/31/18
RILY
08/31/18
DOWNGRADE
RILY
Neutral
Reis downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR downgraded Reis (REIS) to Neutral after the company agreed to be acquired by Moody's (MCO) for $23 per share.
ZBH Zimmer Biomet

10/16/18
LEHM
10/16/18
INITIATION
LEHM
Barclays starts MedTech sector with Positive view
Barclays analyst Kristen Stewart last night initiated coverage of the MedTech sector with a Positive view. The analyst expects the MedTech market to grow 4%-5% "for the foreseeable future" and believes the recent increase in price-to-earnings multiples in the space is warranted given the improving fundamentals. Looking ahead, she thinks relative P/E multiples "should be at least maintained." Stewart initiated coverage on 12 stocks, with Overweight ratings on Abbott (ABT), Boston Scientific (BSX) Stryker (SYK) and Medtronic (MDT). The analyst put Underweight ratings on Baxter (BAX), Edwards Lifesciences (EW) and Zimmer Biomet (ZBH).
10/16/18
PIPR
10/16/18
NO CHANGE
PIPR
Piper Jaffray discusses derivatives from J&J's Q3 results
Piper Jaffray analyst Matt O'Brien notes that Johnson & Johnson's (JNJ) global Medical Devices segment grew 1.7% organically in Q3, with sales of $6.6B falling $50M short of the consensus. The large joint segment continues to look relatively stable, with low-single-digit pricing pressures as expected, O'Brien tells investors in a research note. The analyst suspects Stryker (SYK) will continue to take share away from J&J and Zimmer Biomet (ZBH) in Q3. J&J's Spine segment was flat off of easy comps and after normalizing the Codman divestiture, the analyst adds. He continues to view J&J as a "share donor" to the pure-play spine names Globus Medical (GMED), NuVasive (NUVA) and SeaSpine (SPNE), with Globus' robot "continuing to provide share taking opportunities." Within Contact Lenses, J&J faced tough comps but reported a solid quarter in both the domestic and international markets, O'Brien says. He continues to see a "healthy" lens end market and one that is shifting to daily lenses from reusable, which he views as positive for Cooper Companies (COO). Further, the analyst notes that Diabetes continues to decelerate for J&J at a negative 20% clip given the Animas exit, which he thinks continues to be a positive for the pump names Insulet (PODD) and Tandem Diabetes (TNDM).
10/16/18
10/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Abbott (ABT), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT) were initiated with an Overweight at Barclays, while Baxter (BAX), Edwards Lifesciences (EW), and Zimmer Biomet (ZBH) were initiated with an Underweight. 2. Expedia (EXPE) was initiated with an Outperform at Evercore ISI, while TripAdvisor (TRIP) was initiated with an In Line, and Booking Holdings (BKNG) was initiated with an In Line. 3. Facebook (FB) was initiated with a Buy at Loop Capital and Rosenblatt. 4. Snap (SNAP) initiated with a Hold at Loop Capital. 5. VF Corp. (VFC) initiated with a Neutral at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/15/18
LEHM
10/15/18
INITIATION
LEHM
Underweight
Zimmer Biomet initiated with an Underweight at Barclays
Barclays analyst Kristen Stewart initiated Zimmer Biomet with an Underweight rating and $131 price target.
WY Weyerhaeuser

10/24/18
VERT
10/24/18
UPGRADE
VERT
Buy
Weyerhaeuser upgraded to Buy from Hold at Vertical Research
01/24/18
BOFA
01/24/18
UPGRADE
Target $40
BOFA
Buy
Weyerhaeuser upgraded to Buy on improving pricing at BofA/Merrill
As previously reported, BofA/Merrill upgraded Weyerhaeuser to Buy from Neutral and raised its price target to $40 from $39. Analyst George Straphos views valuation as a "good entry point" ahead of expectations for strong lumber prices and flat-lining timber prices in the South, supporting strong margins in the wood products business. Staphos' research indicates an improved outlook for OSB pricing in 1H 2018, removing a near-term headwind.
01/24/18
BOFA
01/24/18
UPGRADE
BOFA
Buy
Weyerhaeuser upgraded to Buy from Neutral at BofA/Merrill
12/14/17
RAJA
12/14/17
NO CHANGE
RAJA
Raymond James Analysts' Best Picks for 2018
Raymond James named its Analysts' Best Picks for 2018. They are: Alaska Air (ALK), Alibaba (BABA), Becton Dickinson (BDX), Broadcom (AVGO), Continental Resources (CLR), Dollar Tree (DLTR), Fastenal (FAST), First Horizon (FHN), Flir Systems (FLIR), ICU Medical (ICUI), Progressive (PGR),ProPetro Holding (PUMP), ServiceNow (NOW), SS&C (SSNC), SVB Financial (SIVB), UnitedHealth (UNH), and Weyerhaeuser (WY).
GT Goodyear Tire

10/02/18
WOLF
10/02/18
INITIATION
Target $29
WOLF
Outperform
Goodyear Tire initiated with an Outperform at Wolfe Research
Wolfe Research initiated Goodyear Tire with an Outperform and $29 price target.
08/31/18
BREN
08/31/18
DOWNGRADE
Target $23
BREN
Hold
Goodyear Tire downgraded to Hold from Buy at Berenberg
Berenberg analyst Alexander Haissl downgraded Goodyear Tire to Hold and lowered his price target for the shares to $23 from $33. A ramping supply of premium tires will leave the market significantly oversupplied in the medium term, Haissl tells investors in a research note.
08/13/18
08/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Rite Aid (RAD) downgraded to Market Perform from Outperform at Cowen with analyst Charles Rhyee saying shares of Ride Aid adequately reflect its outlook, following the termination of the company's merger with Albertsons. 2. Akamai (AKAM) downgraded to Neutral from Outperform at Credit Suisse with analyst Brad Zelnick saying with the stock up 29% since Elliott Management's disclosure of a stake on December 15, 2017, many of the catalysts have played out. 3. Alnylam (ALNY) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Terence Flynn saying the lack of cardio data in the approved U.S. label for Onpattro is disappointing and could represent a disadvantage versus Pfizer's (PFE) competitor drug Tafamadis. 4. Goodyear Tire (GT) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Armintas Sinkevicius saying he remains "constructive" on the long-term growth for global miles traveled, but believes this will not affect the stock for the next 12 months due to the overhang from estimate achievability. 5. Dish (DISH) downgraded to Sell from Neutral at MoffettNathanson with analyst Craig Moffett saying while the reported Q2 business conditions in the core satellite TV business were "genuinely better" amid reduced churn and slower subscriber losses, the Spectrum segment -- which holds "all" of the company's equity value -- is worse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/13/18
MSCO
08/13/18
DOWNGRADE
Target $23
MSCO
Equal Weight
Goodyear Tire downgraded to Equal Weight from Overweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Armintas Sinkevicius downgraded Goodyear Tire to Equal Weight from Overweight and lowered his price target to $23 from $33, telling investors in a research note that he remains "constructive" on the long-term growth for global miles traveled, but believes this will not affect the stock for the next 12 months due to the overhang from estimate achievability. Going forward, the analyst sees further downward pressure to 2019 estimates, with gradual improvement in U.S. replacement tire demand offset by declines in U.S. SAAR, and says management reiterating 2020 guidance keeps investors on the sidelines in the near term.

TODAY'S FREE FLY STORIES

PTCT

PTC Therapeutics

$40.07

2.67 (7.14%)

17:16
05/21/19
05/21
17:16
05/21/19
17:16
Hot Stocks
Point72 Asset Management takes 5.0% passive stake in PTC Therapeutics »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 31

    May

  • 12

    Jun

DRIO

DarioHealth

$0.72

-0.0095 (-1.30%)

17:10
05/21/19
05/21
17:10
05/21/19
17:10
Syndicate
DarioHealth files to sell common stock, no amount given »

Craig-Hallum Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$113.97

2.08 (1.86%)

, PVH

PVH Corp.

$108.53

2.5075 (2.37%)

17:09
05/21/19
05/21
17:09
05/21/19
17:09
Hot Stocks
PVH Corp. appoints former Ralph Lauren CEO Stefan Larsson to president »

PVH Corp. announced the…

RL

Ralph Lauren

$113.97

2.08 (1.86%)

PVH

PVH Corp.

$108.53

2.5075 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 06

    Jun

  • 20

    Jun

  • 20

    Jun

RICK

RCI Hospitality

$18.91

-0.04 (-0.21%)

17:07
05/21/19
05/21
17:07
05/21/19
17:07
Hot Stocks
RCI Hospitality receives Nasdaq noncompliance notice »

RCI Hospitality Holdings,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPLA

LPL Financial

$83.85

2.06 (2.52%)

17:03
05/21/19
05/21
17:03
05/21/19
17:03
Hot Stocks
LPL Financial to acquire Allen & Company »

LPL Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 11

    Jun

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$286.50

2.55 (0.90%)

17:01
05/21/19
05/21
17:01
05/21/19
17:01
General news
House Judiciary Committee subpoenas Hope Hicks, Annie Donaldson, CNN says »

According to CNN's …

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$286.50

2.55 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$46.90

0.91 (1.98%)

16:53
05/21/19
05/21
16:53
05/21/19
16:53
Conference/Events
Morgan Stanley healthcare tech analyst to hold analyst/industry conference call »

Healthcare Technology and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 23

    Jun

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

, GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

16:48
05/21/19
05/21
16:48
05/21/19
16:48
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

Semiconductor makers…

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

MSFT

Microsoft

$126.90

0.71 (0.56%)

HD

Home Depot

$191.41

0.54 (0.28%)

KSS

Kohl's

$55.15

-7.805 (-12.40%)

JCP

J.C. Penney

$1.06

-0.09 (-7.83%)

CR

Crane

$84.09

-0.8 (-0.94%)

CIR

Circor

$43.09

12.45 (40.63%)

AAPL

Apple

$186.58

3.52 (1.92%)

INTC

Intel

$44.46

0.88 (2.02%)

ARWR

Arrowhead

$21.33

2.39 (12.62%)

ARRY

Array BioPharma

$25.75

4.8 (22.91%)

BCRX

BioCryst

$3.48

-3.92 (-52.97%)

MNK

Mallinckrodt

$9.87

-3.15 (-24.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 24

    May

  • 29

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 11

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 25

    Jul

  • 06

    Aug

  • 27

    Oct

CVI

CVR Energy

$47.29

0.9 (1.94%)

16:46
05/21/19
05/21
16:46
05/21/19
16:46
Hot Stocks
CVR Energy to evaluate strategic alternatives, including 'potential sale' »

CVR Energy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

SFIX

Stitch Fix

$24.57

1.23 (5.27%)

16:46
05/21/19
05/21
16:46
05/21/19
16:46
Hot Stocks
Park West Asset Management reports 5% passive stake in Stitch Fix »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

PTVCA

Protective Insurance

$16.00

(0.00%)

, AIG

AIG

$52.49

0.06 (0.11%)

16:45
05/21/19
05/21
16:45
05/21/19
16:45
Hot Stocks
Protective Insurance appoints Jeremy Johnson as CEO »

Protective Insurance…

PTVCA

Protective Insurance

$16.00

(0.00%)

AIG

AIG

$52.49

0.06 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

TOL

Toll Brothers

$38.34

0.82 (2.19%)

16:43
05/21/19
05/21
16:43
05/21/19
16:43
Hot Stocks
Toll Brothers reports Q2 home sales gross margin 23.5% vs.22.5% last year »

Sees Q3 home sales gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

TDS

Telephone and Data

$31.64

0.245 (0.78%)

16:43
05/21/19
05/21
16:43
05/21/19
16:43
Hot Stocks
Telephone and Data VP Joseph Hanley sells almost $499K in company shares »

Telephone and Data VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

PKOH

Park-Ohio

$35.48

1.03 (2.99%)

16:41
05/21/19
05/21
16:41
05/21/19
16:41
Hot Stocks
Park-Ohio reaches agreement in principle to acquire Erie Press Systems »

ParkOhio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$38.34

0.82 (2.19%)

16:41
05/21/19
05/21
16:41
05/21/19
16:41
Hot Stocks
Toll Brothers CFO sees 'slower demand and rising incentives' in Q3 »

CFO Martin Connor says: …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

16:39
05/21/19
05/21
16:39
05/21/19
16:39
General news
API crude inventories for week of May 17 »

API reports that crude…

G

Genpact

$36.41

0.09 (0.25%)

16:36
05/21/19
05/21
16:36
05/21/19
16:36
Syndicate
Genpact files to sell 10M shares of common stock for holders »

Selling shareholders…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

AL

Air Lease

$37.91

0.68 (1.83%)

, EADSY

Airbus

$0.00

(0.00%)

16:35
05/21/19
05/21
16:35
05/21/19
16:35
Hot Stocks
Air Lease announces delivery of New Airbus A350-900 aircraft to Sichuan Airlines »

Air Lease Corporation…

AL

Air Lease

$37.91

0.68 (1.83%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TOL

Toll Brothers

$38.34

0.82 (2.19%)

16:35
05/21/19
05/21
16:35
05/21/19
16:35
Hot Stocks
Toll Brothers sees Q3 deliveries 1.8K-2.0K units with avg price $855K-$880K »

Sees FY19 deliveries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

FLNT

Fluent

$5.63

0.4 (7.65%)

16:33
05/21/19
05/21
16:33
05/21/19
16:33
Hot Stocks
Fluent promotes Tamara Alesi to CGO »

Fluent announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

TOL

Toll Brothers

$38.34

0.82 (2.19%)

16:33
05/21/19
05/21
16:33
05/21/19
16:33
Hot Stocks
Toll Brothers reports Q2 home building deliveries 1.9K, up 1% »

Reports Q2: Net signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ESRT

Empire State Realty

$15.77

0.18 (1.15%)

16:33
05/21/19
05/21
16:33
05/21/19
16:33
Hot Stocks
Empire State Realty CFO David Karp steps down, Andrew Prentice named acting CFO »

Empire State Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

KHC

Kraft Heinz

$31.98

0.19 (0.60%)

16:33
05/21/19
05/21
16:33
05/21/19
16:33
Hot Stocks
Kraft Heinz still not in compliance with Nasdaq listing rule »

The Kraft Heinz announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$38.34

0.82 (2.19%)

16:31
05/21/19
05/21
16:31
05/21/19
16:31
Earnings
Toll Brothers reports Q2 EPS 87c, consensus 75c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

MYL

Mylan

$19.67

0.225 (1.16%)

16:30
05/21/19
05/21
16:30
05/21/19
16:30
Hot Stocks
FDA: Mylan broadens recall of Valsartan tablets »

Mylan N.V.External Link…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.